A carregar...

Agonists of MAS oncogene and angiotensin II type 2 receptors attenuate cardiopulmonary disease in rats with neonatal hyperoxia-induced lung injury

Stimulation of MAS oncogene receptor (MAS) or angiotensin (Ang) receptor type 2 (AT2) may be novel therapeutic options for neonatal chronic lung disease (CLD) by counterbalancing the adverse effects of the potent vasoconstrictor angiotensin II, consisting of arterial hypertension (PAH)-induced right...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wagenaar, Gerry T. M., Laghmani, El Houari, Fidder, Melissa, Sengers, Rozemarijn M. A., de Visser, Yvonne P., de Vries, Louwe, Rink, Rick, Roks, Anton J. M., Folkerts, Gert, Walther, Frans J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Physiological Society 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3763032/
https://ncbi.nlm.nih.gov/pubmed/23812633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajplung.00360.2012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!